A Pilot Study of Extended Adjuvant Therapy with Metronomic Docetaxel for Patients with Operable Triple-Negative Breast Cancer

BACKGROUND: Triple-negative breast(TNBC) cancer is a molecular subtype of breast cancer with poor prognosis and did not get approved targeted therapy till now. In the last years, metronomic chemotherapy (mCTH) was investigated to improve treatment outcomes in TNBC patients both in early and metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmaksoud, Bader A, Mohamed, Abdelmotaleb, Toam, Mostafa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437317/
https://www.ncbi.nlm.nih.gov/pubmed/32212803
http://dx.doi.org/10.31557/APJCP.2020.21.3.749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437317/
https://www.ncbi.nlm.nih.gov/pubmed/32212803
http://dx.doi.org/10.31557/APJCP.2020.21.3.749

Ejemplares similares